Indivior PLC Faces Class Action Lawsuit from Investors

SAN DIEGO—Robbins LLP has announced that a class action lawsuit has been filed on behalf of investors who purchased Indivior PLC (NASDAQ: INDV) securities between February 22, 2024, and July 8, 2024. The lawsuit alleges that the company and its executives misrepresented their ability to predict the adverse effects of certain legislation on the financial outlook of Indivior’s products, leading to inflated expectations regarding the company’s revenue and financial health. The complaint specifically claims that Indivior overstated the financial prospects of its products, including SUBLOCADE, PERSERIS, and OPVEE. It asserts that the company was aware or should have been aware that it would likely fail to meet its previously issued revenue guidance for fiscal year 2024, particularly for these key products. The situation escalated when Indivior announced on July 9 that it would cease all sales and marketing activities related to PERSERIS, prompting a significant drop in the company’s stock price. Following this announcement, Indivior’s stock plummeted by $5.15 per share, a decline of 33.57%, closing at $10.19. Investors affected by this downturn may be eligible to participate in the class action, which seeks to hold the company accountable for its alleged misrepresentations. Robbins LLP, a firm specializing in shareholder rights litigation, encourages affected investors to reach out for more information on how to participate in the lawsuit. The firm has been dedicated to helping shareholders recover losses and improve corporate governance since 2002.